Build, discover and catalyse


Our goal for BioTrinity 2018 was simple – to create an ideal network and partnering platform for the global life sciences industry under one roof, ultimately to help shape our healthcare future.

Our theme for BioTrinity 2018 was 'Next Generation Healthcare' which was explored via a range of insightful keynote and panel discussions including 'AI and Drug Discovery', 'An insight into Nanotechnology', 'Next Generation Chemistry' and 'The Evolution of the Life Science Investment Industry' - take a look at the full conference programme.

BioTrinity 2019 will take place in LONDON on April 29th - May 1st and will include revisions made on the basis of feedback from delegates at BioTrinity 2018 and innovations from the OBN Team.  Our aim is to continue to provide a unique opportunity for interactions between investors, big pharma executives and innovative CEO's of emerging R&D companies seeking to strike deals and grow their networks.

 

BioTrinity is developed and organised by OBN, the not-for-profit Membership organisation supporting and bringing together the life sciences industry, their corporate partners and investors. For more information on OBN visit our website.

BioTrinity 2017 Highlights

Delegates 860
Companies >450
Representatives from investment firms 150
Representatives from global pharma 75
One-to-One partnering meetings scheduled >2000
Countries represented 27